These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species. Jia F; Wang J; Peng J; Zhao P; Kong Z; Wang K; Yan W; Wang R Amino Acids; 2018 Feb; 50(2):229-239. PubMed ID: 29101485 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial and antibiofilm activity of the EeCentrocin 1 derived peptide EC1-17KV via membrane disruption. Ma L; Ye X; Sun P; Xu P; Wang L; Liu Z; Huang X; Bai Z; Zhou C EBioMedicine; 2020 May; 55():102775. PubMed ID: 32403086 [TBL] [Abstract][Full Text] [Related]
25. Novel antimicrobial peptides based on Protegrin-1: In silico and in vitro assessments. Hosseini Goki N; Saberi MR; Amin M; Fazly Bazzaz BS; Khameneh B Microb Pathog; 2024 Nov; 196():106931. PubMed ID: 39288825 [TBL] [Abstract][Full Text] [Related]
26. Optimized Charge/Hydrophobicity Balance of Antimicrobial Peptides Against Polymicrobial Abdominal Infections. Du K; Yang ZR; Qin H; Ma T; Tang J; Xia J; Zhou Z; Jiang H; Zhu J Macromol Biosci; 2024 May; 24(5):e2300451. PubMed ID: 37997560 [TBL] [Abstract][Full Text] [Related]
27. Salt-resistant short antimicrobial peptides. Mohanram H; Bhattacharjya S Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911 [TBL] [Abstract][Full Text] [Related]
28. A Foundation Model Identifies Broad-Spectrum Antimicrobial Peptides against Drug-Resistant Bacterial Infection. Li T; Ren X; Luo X; Wang Z; Li Z; Luo X; Shen J; Li Y; Yuan D; Nussinov R; Zeng X; Shi J; Cheng F Nat Commun; 2024 Aug; 15(1):7538. PubMed ID: 39214978 [TBL] [Abstract][Full Text] [Related]
29. Exploring the role of unnatural amino acids in antimicrobial peptides. Oliva R; Chino M; Pane K; Pistorio V; De Santis A; Pizzo E; D'Errico G; Pavone V; Lombardi A; Del Vecchio P; Notomista E; Nastri F; Petraccone L Sci Rep; 2018 Jun; 8(1):8888. PubMed ID: 29892005 [TBL] [Abstract][Full Text] [Related]
30. Combining experimental evidence and molecular dynamic simulations to understand the mechanism of action of the antimicrobial octapeptide jelleine-I. Cabrera MP; Baldissera G; Silva-Gonçalves Lda C; Souza BM; Riske KA; Palma MS; Ruggiero JR; Arcisio-Miranda M Biochemistry; 2014 Jul; 53(29):4857-68. PubMed ID: 24971729 [TBL] [Abstract][Full Text] [Related]
31. Manipulating turn residues on de novo designed β-hairpin peptides for selectivity against drug-resistant bacteria. Tram NDT; Selvarajan V; Boags A; Mukherjee D; Marzinek JK; Cheng B; Jiang ZC; Goh P; Koh JJ; Teo JWP; Bond PJ; Ee PLR Acta Biomater; 2021 Nov; 135():214-224. PubMed ID: 34506975 [TBL] [Abstract][Full Text] [Related]
32. BamA-targeted antimicrobial peptide design for enhanced efficacy and reduced toxicity. Yang L; Luo M; Liu Z; Li Y; Lin Z; Geng S; Wang Y Amino Acids; 2023 Oct; 55(10):1317-1331. PubMed ID: 37670010 [TBL] [Abstract][Full Text] [Related]
33. Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap. Mohanram H; Bhattacharjya S Antimicrob Agents Chemother; 2014; 58(4):1987-96. PubMed ID: 24419338 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method. Wu X; Wang Z; Li X; Fan Y; He G; Wan Y; Yu C; Tang J; Li M; Zhang X; Zhang H; Xiang R; Pan Y; Liu Y; Lu L; Yang L Antimicrob Agents Chemother; 2014 Sep; 58(9):5342-9. PubMed ID: 24982064 [TBL] [Abstract][Full Text] [Related]
36. Lipidation of Temporin-1CEb Derivatives as a Tool for Activity Improvement, Pros and Cons of the Approach. Kosikowska-Adamus P; Sikorska E; Wyrzykowski D; Walewska A; Golda A; Deptuła M; Obuchowski M; Prahl A; Pikuła M; Lesner A Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206444 [TBL] [Abstract][Full Text] [Related]
37. Comparing activity, toxicity and model membrane interactions of Jelleine-I and Trp/Arg analogs: analysis of peptide aggregation. Martins DB; Pacca CC; da Silva AMB; de Souza BM; de Almeida MTG; Palma MS; Arcisio-Miranda M; Dos Santos Cabrera MP Amino Acids; 2020 May; 52(5):725-741. PubMed ID: 32367434 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial peptides from C-terminal amphipathic region of E. coli FtsA. Saikia K; Chaudhary N Biochim Biophys Acta Biomembr; 2018 Dec; 1860(12):2506-2514. PubMed ID: 30279152 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials. Green RM; Bicker KL Int J Antimicrob Agents; 2020 Aug; 56(2):106048. PubMed ID: 32540430 [TBL] [Abstract][Full Text] [Related]
40. The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L. Buommino E; Carotenuto A; Antignano I; Bellavita R; Casciaro B; Loffredo MR; Merlino F; Novellino E; Mangoni ML; Nocera FP; Brancaccio D; Punzi P; Roversi D; Ingenito R; Bianchi E; Grieco P ChemMedChem; 2019 Jul; 14(13):1283-1290. PubMed ID: 31087626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]